Hyun Y. Park
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Atraric acid enhances neuronal survival and cognition against D-galactose-induced neurodegeneration via BDNF/TrkB/AKT signaling.
Journal: Inflammopharmacology
Published: May 29, 2026
SVO70 (Optimal Target Low-Density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke): Rationale and Study Design.
Journal: Journal of the American Heart Association
Published: April 28, 2026
Neuroprotective Effect of Isorhapontigenin (ISO) Against LPS-Induced Neurodegenerative Condition via TLR4/RAGE-Mediated p-NF-kB Activation.
Journal: Molecular neurobiology
Published: March 27, 2026
Therapeutic effect of faricimab in macular telangiectasia type 1 and Coats' disease: case series.
Journal: BMC ophthalmology
Published: December 22, 2025
Atraric acid mitigates the cognitive and pathological deficits in mice via Aβ1-42 induced Alzheimer's disease.
Journal: Inflammopharmacology
Published: October 28, 2025
Dynamic realignment of extraocular muscles after inferomedial orbital wall decompression in thyroid eye disease: a 3D CT reconstruction study.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
Published: September 23, 2025
Lupeol restores dopaminergic function by suppressing glial activation in a Parkinson's disease mouse model.
Journal: Frontiers in immunology
Published: September 19, 2025
Osmotin-derived 9-amino-acid peptide alleviates α-synuclein and MPTP-induced glial cell activation mediated neuroinflammation, protecting dopaminergic neurons in Parkinson's disease mice brain.
Journal: Journal of biomedical science
Published: July 16, 2025
Therapeutic effect of IL-11 inhibition on the pathogenesis of thyroid eye disease.
Journal: Journal of molecular endocrinology
Published: June 02, 2025
Neuroprotective effects of saikosaponin-A in ethanol-induced glia-mediated neuroinflammation, oxidative stress via RAGE/TLR4/NFkB signaling.
Journal: Frontiers in cellular neuroscience
Published: May 08, 2025
The mGluR2/3 agonist xanthurenic acid improves memory, attention, and synaptic deficits by modulating glutamate release in Alzheimer's disease model.
Journal: Acta pharmacologica Sinica
Published: May 02, 2025
Last Updated: 09/26/2026